Stephen Forman
Tracked across 1 events · 6 articles · First seen Jul 20, 2026 · Last active Sep 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
PeproMene Bio announced the publication in The Lancet of results from its Phase 1 clinical trial of PMB-CT01, a first-in-class BAFF-R-targeted CAR T-cell therapy, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. The trial…
Impact: Stephen Forman, as co-author and director at City of Hope, contributed to the trial's success. The results bolster his reputation in hematologic malignancies research.
Jul 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Stephen Forman live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard